CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies...
-- Study meets one of the two analyses of primary efficacy endpoint: statistically significant dose-response in six-minute walk test (6MWT)...
Guidance across all programs remains unchanged for expected data and clinical development milestones in 2021LONDON, Aug. 13, 2021 (GLOBE NEWSWIRE)...
OTTAWA, Aug. 13, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) announced today it...
Company Believes All Issues Are Addressable and it Will Be Able to Continue BLA Resubmission CMC and Non-Clinical Sections Will...
In relation to the previously announced JSC AB CITY mandatory repurchase of JSC Olainfarm shares, Financial and Capital Market Commission has published the...
VANCOUVER, British Columbia, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN:...
Company announcement, Inside Information, Helsinki, 13 August 2021 at 09:00 am (EEST) NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30...
Message from the CEO As is well known, IBT is conducting a large phase III study ("The Connection Study"), the...
Pixium Vision announces geographical expansion of PRIMAvera European pivotal study with opening of first UK clinical site at Moorfields Eye...
SEATTLE and CAMBRIDGE, United Kingdom, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (NASDAQ: ELYM), a clinical-stage biotechnology company...
NEW YORK and BOULDER, Colo., Aug. 12, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a...
Initiated preclinical animal studies for MN-166 as a treatment for chlorine gas-induced induced lung disease under partnership with BARDA Positive...
Newport Beach, CA, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed...
BRIDGEWATER, N.J., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated...
Conference Call to be held on Monday, August 23rd, 2021 at 5:00 PM ESTNEW HAVEN, Conn., Aug. 12, 2021 (GLOBE...
MENLO PARK, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the...
The exclusively licensed platform has potential application for any tumor target Preclinical development to continue at Mayo Clinic Mustang to...
SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed...
Clinical trial programs for vidutolimod (CMP-001) in melanoma and head and neck cancer indications ongoing Trial start-up activities to support...
